David Roulois
Impact in
- Immunology top 5%
- Immunotherapy and Immune Responses
- interferon and immune responses
- Immune Cell Function and Interaction
- Immune cells in cancer
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
Papers in
- Immunology 13
- Immunotherapy and Immune Responses 7
- IL-33, ST2, and ILC Pathways 4
- T-cell and B-cell Immunology 4
- interferon and immune responses 2
- Co-authors
- Daniel D. De CarvalhoHelen Loo YauRajat SinghaniaHan HanTrevor J. PughShu Yi ShenPeter A. JonesCatherine O′Brien
- Journals
- Oncotarget (3 papers)Stem Cells (1 paper)Clinical Cancer Research (1 paper)Journal of Thoracic Oncology (1 paper)Frontiers in Immunology (1 paper)
- Partner nations
- FranceUnited KingdomCanada
In The Last Decade
David Roulois
19 papers receiving 1.5k citations
Hit Papers
Peers
Comparison fields: 5 of 76
- Immunology 641
- Oncology 439
- Molecular Biology 887
- Cancer Research 164
- Hematology 102
Countries citing papers authored by David Roulois
This map shows the geographic impact of David Roulois's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Roulois with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Roulois more than expected).
Fields of papers citing papers by David Roulois
This network shows the impact of papers produced by David Roulois. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Roulois. The network helps show where David Roulois may publish in the future.
Co-authorship network
The 25 scholars most cited alongside David Roulois, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2023 | 5 | |
| 4 | 2022 | 15 | |
| 5 | 2022 | 7 | |
| 6 | 2021 | 17 | |
| 7 | 2019 | 60 | |
| 8 | 2019 | 138 | |
| 9 | 2019 | 11 | |
| 10 | 2018 | 1 | |
| 11 | 2016 | 23 | |
| 12 | 2016 | 15 | |
| 13 | 2015 | 23 | |
| 14 | DNA-Demethylating Agents Target Colorectal Cancer Cells by Inducing Viral Mimicry by Endogenous Transcripts Hit paper breakdown → | 2015 | 987 |
| 15 | 2015 | 32 | |
| 16 | 2013 | 97 | |
| 17 | 2012 | 27 | |
| 18 | 2012 | 35 | |
| 19 | 2011 | 12 | |
| 20 | 2011 | 13 |
About David Roulois
David Roulois is a scholar working on Immunology, Animal Science and Zoology, Genetics, Immunology and Allergy and Oncology, having authored 20 papers that have together received 1.5k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (7 papers), Epigenetics and DNA Methylation (4 papers), IL-33, ST2, and ILC Pathways (4 papers), T-cell and B-cell Immunology (4 papers), Occupational and environmental lung diseases (3 papers), interferon and immune responses (2 papers), Virus-based gene therapy research (2 papers) and Mesenchymal stem cell research (2 papers). The work is most often cited by research in Immunology (641 citations), Oncology (439 citations), Molecular Biology (887 citations), Cancer Research (164 citations) and Hematology (102 citations). David Roulois has collaborated with scholars based in France, United Kingdom and Canada. Frequent co-authors include Daniel D. De Carvalho, Helen Loo Yau, Rajat Singhania, Han Han, Trevor J. Pugh, Shu Yi Shen, Peter A. Jones, Catherine O′Brien, Arnavaz Danesh and Gangning Liang. Their work appears in journals such as Oncotarget, Stem Cells, Clinical Cancer Research, Journal of Thoracic Oncology and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.